Solid-phase binding assay of biotinylated VEGF to recombinant human VEGFR1–2

FN Florence Njau
NS Nelli Shushakova
HS Heiko Schenk
VW Vera Christine Wulfmeyer
RB Robin Bollin
JM Jan Menne
HH Hermann Haller
request Request a Protocol
ask Ask a question
Favorite

The method was performed as described previously [31]. Briefly, 96-well microplate was coated with 500 ng/ml of either VEGFR-1 or -2 in PBS, sealed and incubated overnight at 4°C. After 3 times washes with PBS-Tween 20 (0.05% v/v), the plate was blocked with PBS with 1% (w/v) BSA, and incubated for 2 h at room temperature. After washing, a mixture of bt-VEGF (50ng/ml) and heparin (1 μg/ml) or various concentrations of CaD in PBS were applied overnight at 4°C. After washing, streptavidin-HRP (1:4000) was added for 2 h, washed and substrate solution was added for 30–45 minutes. Stop solution (2N; H2SO4) was added and fluorescence was measured at 450nm.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A